Ajou University repository

Vaccine
ISSN
  • E1358-8745
  • P0264-410X
Publisher

Elsevier BV

Listed on
(Coverage)

JCR1997-2023

SJR1999-2020;2022-2023

CiteScore2011-2023

SCI2010-2019

SCIE2010-2024

CC2016-2024

SCOPUS2017-2024

MEDLINE2016-2024

EMBASE2016-2024

Active
Active

based on the information

  • SCOPUS:2024-10
Country
ENGLAND
Aime & Scopes
Vaccine has an open access mirror journal Vaccine: X, sharing the same aims and scope, editorial team, submission system and rigorous peer review. Vaccine is unique in publishing the highest quality science across all disciplines relevant to the field of vaccinology - all original article submissions across basic and clinical research, vaccine manufacturing, history, public policy, behavioral science and ethics, social sciences, safety, and many other related areas are welcomed. Our submission categoriesindicate where we receive the most papers. Papers outside these major areas are also welcome and authors are encouraged to contact us with specific questions. We also invite authors to submit relevant basic science and clinical reviews, methodological articles, opinion and commentary pieces, visual pieces, and letters. Authors are required to consult the Guide for Authors as this is a dynamic set of submission guidelines and is therefore subject to change. The Editors retain the right to desk reject submissions without peer review where it is clear that the Guide for Authors and the submission categories have not been consulted.
Article List

Showing results 1 to 2 of 2

Potential of a bivalent vaccine for broad protection against enterovirus 71 and coxsackie virus 16 infections causing hand, foot, and mouth disease
  • Yi, Eun Je;
  • Kim, Young In;
  • Song, Jae Hyoung;
  • Ko, Hyun Jeong;
  • Ahn, Sung Hyun;
  • Lee, Hyoung Jin;
  • Suh, Bohyun;
  • Yu, Jaelim;
  • Park, Jeehye;
  • Lee, Yoon Jung;
et al
  • 2023-09-22
  • Vaccine, Vol.41 No.41, pp.6055-6063
  • Elsevier Ltd
Intranasal immunization with curdlan induce Th17 responses and enhance protection against enterovirus 71
  • 2023-03-24
  • Vaccine, Vol.41 No.13, pp.2243-2252
  • Elsevier Ltd
1